SC 13G ·Filed Oct 1, 2026
Passive investor 5%+ stake
Actionable Insight • Neutral
Passive 13G filing signals institutional interest but no activist intent. Monitor for any future conversion to 13D or additional stake increases.
Latest settled — T+5d ⚠ clustered
ADRX ▼ -2.58% at T+5d
NEUTRAL call -2.58% · α vs SPY -3.74% · entry $18.25 → $17.78
T+1d
+4.38%
call +4.38% · α +3.71%
$19.05
settled 26d ago
T+5d
-2.58%
call -2.58% · α -3.74%
$17.78
settled 20d ago
T+20d
Pending
tomorrow
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
BCLS Fund III Investments, LP (a Bain Capital Life Sciences entity) disclosed a 6.3% passive stake in ADARx Pharmaceuticals via Schedule 13G, holding 6,728,970 shares. The filing certifies no intent to influence control, making this a routine passive investment disclosure.
Key Financial Metrics
Stake
6.3%
Investor
BCLS Fund III Investments, LP
Key Facts
- BCLS Fund III Investments, LP holds 6,728,970 shares of ADARx common stock.
- Stake represents approximately 6.3% of outstanding shares based on 106,801,325 shares outstanding.
- Filing is a passive Schedule 13G with certification of no control intent.
- Investor is a Bain Capital Life Sciences entity, a healthcare-focused investment firm.
Financial Impact
6.3% passive stake valued at approximately $[●] (undisclosed market value at filing date).
ownership concentration
Risk Factors
- No explicit risk of activism given passive filing certification.
- Stake is below typical threshold for board influence or control.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001193125-26-410626 |
| Document: 0001193125-26-410626-index.html | 0001193125-26-410626 |
| Document: 0001193125-26-410626.txt | 0001193125-26-410626 |
16 reports for ADRX
67% Hit rate @ T+1 Went positive at some point 4 of 6 best @ T+1▲ +4.38%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | SC 13G | $17.63 $17.68 | ▲ +0.28% | ▼ −0.05% | $18.13 (+2.84%) |
Oct 5, 2026 22d ago | SC 13D | $18.58 $17.33 | ▼ −6.73% | ▼ −6.49% | $18.13 (−2.42%) |
Oct 2, 2026 25d ago | SC 13D | $19.05 $18.58 | ▼ −2.47% | ▼ −3.02% | $18.13 (−4.83%) |
Oct 1, 2026 26d ago | Press Release | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $18.13 (−0.66%) |
Oct 1, 2026 26d ago | SC 13G | $18.25 $19.05 | ▲ +4.38% | ▲ +3.71% | $18.13 (−0.66%) |
Sep 30, 2026 27d ago | Insider Cluster | $19.54 $18.25 | ▼ −6.60% | ▼ −7.34% | $18.13 (−7.22%) |
Sep 29, 2026 28d ago | Insider Cluster | $19.94 $19.54 | ▼ −2.01% | ▼ −2.18% | $18.13 (−9.08%) |
Sep 25, 2026 4w ago | 424B4 | $20.09 $20.64 | ▲ +2.71% | ▲ +2.90% | $18.13 (−9.76%) |
Sep 25, 2026 4w ago | EFFECT | $19.35 $20.09 | ▲ +3.82% | ▲ +4.57% | $18.13 (−6.30%) |
Sep 24, 2026 4w ago | Press Release | $19.35 $20.09 | ▲ +3.82% | ▲ +4.57% | $18.13 (−6.30%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Thu (11h 44m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers